Javier Mercapide

685 total citations
15 papers, 515 citations indexed

About

Javier Mercapide is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Javier Mercapide has authored 15 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology and Allergy. Recurrent topics in Javier Mercapide's work include Cell Adhesion Molecules Research (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer Research and Treatments (3 papers). Javier Mercapide is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer Research and Treatments (3 papers). Javier Mercapide collaborates with scholars based in United States, Spain and Germany. Javier Mercapide's co-authors include Germana Rappa, Aurelio Lorico, Fabio Anzanello, R. Marshall Pope, Øystein Fodstad, Javier S. Castresana, Andres J. Klein–Szanto, Ricardo López de Cicco, Juan J. Martínez‐Irujo and Esteban Santiago and has published in prestigious journals such as PLoS ONE, Biochemical Journal and American Journal Of Pathology.

In The Last Decade

Javier Mercapide

15 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Mercapide United States 12 309 205 156 83 63 15 515
Erkan Yuca United States 11 323 1.0× 188 0.9× 100 0.6× 51 0.6× 37 0.6× 21 492
Anna Fantozzi Italy 9 542 1.8× 287 1.4× 169 1.1× 21 0.3× 83 1.3× 9 792
Tiziana Tonini United States 11 431 1.4× 229 1.1× 143 0.9× 28 0.3× 58 0.9× 15 646
Galina M. Kiriakova United States 10 380 1.2× 310 1.5× 210 1.3× 25 0.3× 169 2.7× 11 707
Zonghui Ding United States 13 442 1.4× 125 0.6× 275 1.8× 61 0.7× 58 0.9× 18 676
Xueming Zhu United States 8 307 1.0× 179 0.9× 160 1.0× 149 1.8× 51 0.8× 8 501
Janet E. Price United States 9 294 1.0× 286 1.4× 111 0.7× 26 0.3× 109 1.7× 9 564
Juan Manuel Iglesias Spain 10 366 1.2× 287 1.4× 139 0.9× 16 0.2× 67 1.1× 12 604
Umberto Restuccia Italy 11 417 1.3× 131 0.6× 144 0.9× 72 0.9× 149 2.4× 14 677
Avinash Ghanate India 8 508 1.6× 383 1.9× 201 1.3× 26 0.3× 33 0.5× 14 764

Countries citing papers authored by Javier Mercapide

Since Specialization
Citations

This map shows the geographic impact of Javier Mercapide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Mercapide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Mercapide more than expected).

Fields of papers citing papers by Javier Mercapide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Mercapide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Mercapide. The network helps show where Javier Mercapide may publish in the future.

Co-authorship network of co-authors of Javier Mercapide

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Mercapide. A scholar is included among the top collaborators of Javier Mercapide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Mercapide. Javier Mercapide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mercapide, Javier & Aurelio Lorico. (2014). Adhesion signaling promotes protease-driven polyploidization of glioblastoma cells. International Journal of Molecular Medicine. 34(5). 1365–1371. 1 indexed citations
2.
Rappa, Germana, Javier Mercapide, Fabio Anzanello, et al.. (2013). Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells. Experimental Cell Research. 319(6). 810–819. 42 indexed citations
3.
Rappa, Germana, Javier Mercapide, Fabio Anzanello, R. Marshall Pope, & Aurelio Lorico. (2013). Biochemical and biological characterization of exosomes containing prominin-1/CD133. Molecular Cancer. 12(1). 62–62. 94 indexed citations
4.
Mercapide, Javier, Fabio Anzanello, Germana Rappa, & Aurelio Lorico. (2012). Relationship between Tumor Cell Invasiveness and Polyploidization. PLoS ONE. 7(12). e53364–e53364. 6 indexed citations
5.
Lorico, Aurelio, Javier Mercapide, & Germana Rappa. (2012). Prominin-1 (CD133) and Metastatic Melanoma: Current Knowledge and Therapeutic Perspectives. Advances in experimental medicine and biology. 777. 197–211. 7 indexed citations
6.
Rappa, Germana, Javier Mercapide, & Aurelio Lorico. (2012). Spontaneous Formation of Tumorigenic Hybrids between Breast Cancer and Multipotent Stromal Cells Is a Source of Tumor Heterogeneity. American Journal Of Pathology. 180(6). 2504–2515. 82 indexed citations
7.
Mercapide, Javier, Germana Rappa, & Aurelio Lorico. (2011). The intrinsic fusogenicity of glioma cells as a factor of transformation and progression in the tumor microenvironment. International Journal of Cancer. 131(2). 334–343. 16 indexed citations
8.
Mercapide, Javier, Germana Rappa, Fabio Anzanello, et al.. (2009). Primary gene‐engineered neural stem/progenitor cells demonstrate tumor‐selective migration and antitumor effects in glioma. International Journal of Cancer. 126(5). 1206–1215. 29 indexed citations
9.
Lorico, Aurelio, et al.. (2008). Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma. Cancer Gene Therapy. 15(9). 605–615. 19 indexed citations
10.
Rappa, Germana, Javier Mercapide, Fabio Anzanello, et al.. (2008). Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Experimental Cell Research. 314(10). 2110–2122. 70 indexed citations
11.
Inda, María del Mar, Javier Mercapide, Philippe Coullin, et al.. (2004). PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors. Oncology Reports. 12(6). 1341–7. 17 indexed citations
12.
Mercapide, Javier, Ricardo López de Cicco, Javier S. Castresana, & Andres J. Klein–Szanto. (2003). Stromelysin‐1/matrix metalloproteinase‐3 (MMP‐3) expression accounts for invasive properties of human astrocytoma cell lines. International Journal of Cancer. 106(5). 676–682. 55 indexed citations
13.
Mercapide, Javier, Shi Yu Zhang, Xing Fan, et al.. (2002). CCND1‐ and ERBB2‐gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast. Molecular Carcinogenesis. 35(1). 6–12. 12 indexed citations
14.
Mercapide, Javier, Esteban Santiago, Elena Alberdi, & Juan J. Martínez‐Irujo. (1999). Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Biochemical Pharmacology. 58(10). 1675–1683. 26 indexed citations
15.
Martínez‐Irujo, Juan J., et al.. (1998). Analysis of the combined effect of two linear inhibitors on a single enzyme. Biochemical Journal. 329(3). 689–698. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026